***Tune in to an all-new edition of “Inside the Blueprint” for this full story! Airing June 28 at 5p ET on Bloomberg US and June 29 at 5p ET on Fox Business***
It’s an eye disease affecting millions of Americans and people worldwide. Known commonly as dry-eye disease, it is a debilitating condition that can be more than a mere nuisance. In some persons, advanced dry eye disease can affect vision — permanently. One visionary company, literally and figuratively, Novoxel, is pioneering an advanced treatment — technology that is mitigating the effects of dry eye. Tixel i® is an FDA-cleared device for the application of localized heat and pressure therapy in adult patients. Treatment for both eyes takes two minutes and can result in dry-eye improvement lasting up to 6 months in some patients. We visited the company’s headquarters in Knoxville, TN, to find out more.
